HIGHLIGHTS
- who: govindpharma143@outlook.com from the University Emergency Elias Hospital Bucharest, Romania have published the research: Prognostic Factors in First-line Metastatic Renal Cell Carcinoma: How to Improve the Prognostic Ability of the IMDC and MSKCC Score?, in the Journal: (JOURNAL)
- what: This study aimed to evaluate which risk factors from the MSKCC and IMDC models more accurate correlated with survival in advanced kidney cancer. This study showed that four variables that distinguish itself from previous IMDC and MSKCC (Karnofsky performance status and amp;lt;80, time from RCC diagnosis to first-line therapy and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.